Huntingtin DNA, protein and uses thereof

Details Huntingtin DNA, protein and uses thereof Huntingtin DNA, protein and uses thereof

1995-05-30

1997-12-02

Wax, Robert A.

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

435 691, 4352523, 4353201, C07K 100, C12P 2106, C12N 120, C12N 1500

Patent

active

056937571

ABSTRACT:
A novel gene, huntingtin, is described, encoding huntingtin protein, recombinant vectors and hosts capable of expressing huntingtin. Methods for the diagnosis and treatment of Huntington's disease are also provided.

REFERENCES:
patent: 4666828 (1987-05-01), Gusella
patent: 5534438 (1996-07-01), Hayden et al.
Dode, C., et al., "Huntington's Disease in French Families: CAG Repeat Expansion and Linkage Disequilibrium Analysis," C.R. Acad. Sci. Paris III 316(11):1374-1380 (Nov. 1993).
Laurent, B.C., et al., "The SNF5 Protein of Saccharomyces cerevisiae Is a Glutamine-and Proline-Rich Transcriptional Activator That Affects Expression of a Broad Spectrun of Genes," Mol. Cell. Biol. 10(11):5616-5625 (Nov. 1990).
Riess, O., et al., "Improved PCR Conditions for the Stretch of (CAG).sub.n Repeats Causing Huntington's Disease," Hum. Mol. Genet. 2(6):637 (Jun. 1993).
Warner, J.P., et al., "A New Polymerase Chain Reaction (PCR) Assay for the Trinucleotide Repeat That is Unstable and Expanded on Huntington's Disease Chromosomes," Mol. Cell. Probes 7(3):235-239 (Jun. 1993).
A copy of the European Search Report for corresponding European Patent Application No. EP 94301587, EPO Publication No. 0 614 977.
Allitto, B.A. et al., "Increased recombination adjacent to the Huntington disease-linked D4S10 marker," Genomics 9:104-112 (1991).
Altherr, M.R. et al., "Radiation hybrid map spanning the Huntington disease gene region of chromosome 4," Genomics 13:1040-1046 (1992).
Altschul, S.F. et al., "Basic local alignment search tool," J. Mol. Biol. 215:403-410 (1990).
Ambrose, C. et al., "A novel G protein-coupled receptor kinase gene cloned from 4p16.3," Hum. Mol. Genet. 1(9):697-703 (1992).
Anderson, M.A. and Gusella, J.F., "Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines," In Vitro 20(11):856-858 (Nov. 1984).
Andrew, S.E. et al., "The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's Disease," Nature Genet. 4:398-403 (Aug. 1993).
Ashizawa, T. and Epstein, H.F., "Ethnic distribution of myotonic dystrophy gene," Lancet 338:642-643 (Sep. 7, 1991).
Aslanidis, C. et al., "Cloning of the essential myotonic dystrophy region and mapping of the putative defect," Nature 355:548-551 (Feb. 6, 1992).
Bates, G.P. et al., "Defined physical limits of the Huntington disease gene candidate region," Am. J. Hum. Genet. 49:7-16 (1991).
Bates, G.P. et al., "Characterization of a yeast artificial chromosome contig spanning the Huntington's disease gene candidate region," Nature Genet. 1:180-187 (Jun. 1992).
Bates, G.P. et al., "A yeast artificial chromosome telomere clone spanning a possible location of the Huntington disease gene," Am. J. Hum. Genet. 46:762-775 (1990).
Baxendale, S. et al., "The direct screening of cosmid libraries with YAC clones," Nucleic Acids Res. 19(23):6651 (1991).
Biancalana, V. et al., "Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy," Hum. Mol. Genet. 1(4):255-258 (1992).
Brook, J.D. et al., "Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member," Cell 68:799-808 (Feb. 21, 1992).
Brunner, H.G. et al., "Brief report: reverse mutation in myotonic dystrophy," N. Engl. J. Med. 328:476-480 (Feb. 18, 1993).
Bucan, M. et al., "Physical maps of 4p16.3, the area expected to contain the Huntington disease mutation," Genomics 6:1-15 (1990).
Buckler, A.J. et al., "Exon amplification: a strategy to isolate mammalian genes based on RNA splicing," Proc. Natl. Acad. Sci. USA 88:4005-4009 (May 1991).
Buxton, J. et al., "Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy," Nature 355:547-548 (Feb. 6, 1992).
Cheng, S.V. et al., "Synteny on Mouse Chromosome 5 of Homologs for Human DNA Loci Linked to the Huntington Disease Gene," Genomics 5:304-308 (1989).
Conneally, P.M. et al., "Huntington disease: no evidence for locus heterogeneity," Genomics 5:304-308 (1989).
Daly, C.B., "Genetic cause is identified for Huntington's disease," The Washington Post, Mar. 24, 1993.
DeBoulle, K. et al., "A point mutation in the FMR-1 gene associated with fragile X mental retardation," Nature Genet. 3:31-35 (Jan. 1993).
Doucette-Stamm, L.A. et al., "Generation and characterization of irradiation hybrids of human chromosome 4," Somat. Cell Mol. Genet. 17(5):471-480 (1991).
Duyao, M. et al., "Trinucleotide repeat length instability and age of onset in Huntington's Disease," Nature Genet. 4:387-392 (Aug. 1993).
Fu Y.H. et al., "An unstable triplet repeat in a gene related to myotonic muscular dystrophy," Science 255:1256-1259 (Mar. 6, 1992).
Fu, Y.H. et al., "Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox," Cell 67:1047-1058 (Dec. 20, 1991).
Goldberg, Y.P. et al., "Identification of an Alu retrotransposition event in close proximity to a strong candidate gene for Huntington's disease," Nature 362:370-373 (Mar. 25, 1993).
Goodfellow, P.N., "Planting alfalfa and cloning the Huntington's disease gene," Cell 72:817-818 (Mar. 26, 1993).
Gusella, J.F., "Chapter 3--Huntington's disease," Adv. Hum. Genet. 20:125-151 (1991).
Gusella, J.F., "Location cloning strategy for characterizing genetic defects in Huntington's disease and Alzheimer's disease," FASEB J. 3:2036-2041 (1989).
Gusella, J.F. and MacDonald, M.E., "Hunting for Huntington's Disease," in: Molecular Genetic Medicine, vol. 3 Academic Press, Inc., San Diego, CA, pp. 139-158 (Aug. 1993).
Gusella, J.F. et al. "DNA markers for nervous system diseases," Science 225:1320-1326 (Sep. 21, 1984).
Gusella, J.F. et al., "A polymorphic DNA marker genetically linked to Huntington's disease," Nature 306:234-238 (Nov. 17, 1983).
Gusella, J.F. et al., "Precise localization of human .beta.-globin gene complex on chromosome 11," Proc. Natl. Acad. Sci. USA 76(10):5239-5243 (Oct. 1979).
Harley, H.G. et al., "Detection of linkage disequilibrium between the myotonic dystrophy and a new polymorphic DNA marker," Am. J. Hum. Genet. 49:68-75 (1991).
Harley, H.G. et al., "Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy," Nature 355:545-546 (Feb. 6, 1992).
Harley, H.G. et al., "Unstable DNA sequence in myotonic dystrophy," Lancet 339:1125-1128 (May 9, 1992).
Harper, P.S., "The epidemiology of Huntington's disease," Hum. Genet. 89:365-376 (1992).
Hoogeveen, A.T. et al., "Characterization and localization of the Huntington disease gene product," Hum. Mol. Genet. 2(12):2069-2073 (Dec. 1993).
Jerome, R., "Huntington's cornered," The Sciences, p. 7 (May/Jun. 1993).
Kremer, E.J. et al., "Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n," Science 252:1711-1714 (Jun. 21, 1991).
LaSpada, A.R. et al., "Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy," Nature 352:77-79 (Jul. 4, 1991).
Lin, B. et al., "Differential 3' polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression," Hum. Mol. Genet. 2(10) :1541-1545 (Oct. 1993).
Lin, B. et al., "Sequence of the murine Huntington disease gene: evidence for conservation, and polymorphism in a triplet (CCG) repeat alternate splicing," Hum. Mol. Genet. 3(1) :85-92 (1994).
Lin, C.S. et al., "New DNA markers in the Huntington's disease gene candidate region," Somat. Cell Mol. Genet. 17(5):481-488 (1991).
Little, P. "The end of the beginning," Nature 362:408-409 (Apr. 1, 1993).
MacDonald, M.E. et al., "Clustering of multiallele DNA markers near the Huntington's disease gene," J. Clin. Inv. 84:1013-1016 (Sep. 1989).
MacDonald, M.E. et al., "Complex patterns of linkage disequilibrium in the Huntington disease region," Am. J. Hum. Genet. 49:723-734 (1991).
MacDonald, M.E. et al., "Gametic but not somatic instability of CAG repeat length in Huntington's disease," J. Med. Genet. 30(12) :982-986 (Dec. 1993).
MacDonald, M.E. et al., "The Huntington's disease candidate region exhibits many different haplotypes," Natur

Affiliated with

Also associated with

Rating

Huntingtin DNA, protein and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Huntingtin DNA, protein and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Huntingtin DNA, protein and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-802571